About M3 Helse AS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Boehringer Ingelheim
2
Clinical Trials at M3 Helse AS
During the past decade, M3 Helse AS conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
2015-12-22
2017-09-20
Completed
977
A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain
2021-01-22
2021-10-18
Terminated
154
A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.
2021-05-31
2022-05-19
Withdrawn
0
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "M3 Helse AS"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at M3 Helse AS
According to Clinical.Site data, the most researched conditions in "M3 Helse AS" are
"Chronic Kidney Disease" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetic Kidney Disease" (1 trials) and "Neuropathic Pain Associated With Diabetic Peripheral Neuropathy" (1 trials). Many other conditions were trialed in "M3 Helse AS" in a lesser frequency.
Clinical Trials Intervention Types at M3 Helse AS
Most popular intervention types in "M3 Helse AS" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "BAY1817080" (1 trials), "BAY2327949" (1 trials), "Empagliflozin" (1 trials) and "Placebo for BAY1817080" (1 trials). Other intervention names were less common.
Clinical Trials Genders at M3 Helse AS
The vast majority of trials in "M3 Helse AS" are
4 trials for "All" genders.
Clinical Trials Status at M3 Helse AS
Currently, there are NaN active trials in "M3 Helse AS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in M3 Helse AS,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in M3 Helse AS, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".